Grape Seed Extract Attenuates Hepatitis C Virus Replication and Virus-Induced Inflammation

Area of Science:

• Hepatology
• Virology
• Natural Product Chemistry

Background:

• Hepatitis C virus (HCV) infection is a major cause of hepatocellular carcinoma, linked to chronic inflammation and cirrhosis.
• Understanding the mechanisms of HCV pathogenesis and identifying novel therapeutic targets are crucial for disease management.

Purpose of the Study:

• To investigate the anti-HCV effects of grape seed extract (GSE).
• To elucidate the underlying mechanisms by which GSE impacts HCV replication and associated inflammatory pathways.

Main Methods:

• In vitro assessment of GSE's effect on HCV replication.
• Analysis of cyclooxygenase-2 (COX-2) expression and its modulation by GSE.
• Investigation of signaling pathways including NF-κB and MAPK/ERK/JNK.
• Evaluation of GSE's impact on inflammatory cytokine gene expression.
• Assessment of synergistic anti-HCV effects of GSE in combination with standard antiviral therapies.

Main Results:

• GSE treatment exhibited significant anti-HCV activity.
• GSE suppressed elevated cyclooxygenase-2 (COX-2) expression induced by HCV.
• The antiviral effect of GSE was correlated with the inactivation of IKK-regulated NF-κB and MAPK/ERK/JNK signaling pathways.
• GSE attenuated HCV-induced inflammatory cytokine gene expression.
• Combined administration of GSE with interferon or other antiviral drugs showed synergistic anti-HCV effects.

Conclusions:

• Grape seed extract possesses significant anti-HCV properties.
• GSE inhibits HCV replication by targeting aberrant COX-2 expression and related inflammatory signaling pathways.
• GSE shows potential as a complementary dietary supplement for managing chronic HCV infection, possibly enhancing the efficacy of existing antiviral treatments.